|Day Low/High||5.55 / 5.85|
|52 Wk Low/High||2.93 / 4.62|
Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought in a lawsuit against Suzhou,...
Codexis to Research and Develop Novel Enzymes Supporting Tate & Lyle's Food Ingredient Growth Strategies
Enzyme developed with CodeEvolver® technology for preclinical therapeutics program exceeds agreement requirements
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.